CVE-2022-48226: An issue was discovered in Acuant AcuFill SDK before 10.22.02.03

Q: How do I fix CVE-2022-48226?

acuant acufill sdk: upgrade to 10.22.02.03. Exact commands for each OS are on this page.

Q: Is CVE-2022-48226 being exploited?

CVE-2022-48226 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

Q: What does CVE-2022-48226 affect?

CVE-2022-48226 affects acuant acufill sdk. Severity is high (CVSS 7.8). An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need

Routine

HIGH 7.8UPGRADE

CVE-2022-48226 is a high-severity flaw (CVSS 7.8) affecting acuant acufill sdk. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.

Why this priority

High severity

A fixed release or distro patch exists.

Risk facts

CVSS score	7.8 (High)
Attack vector	Local
Attack complexity	Low
Privileges needed	Low
User interaction	None
EPSS exploit chance	0.2% (top 92%)
CISA exploited list	No
Weakness	CWE-269
Published	2023-04-04
Last modified	2026-06-17

Publisher (CNA): MITRE · Vendor: gbgplc

Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score

Am I affected?

Timeline

2023-04-04 15:15 UTCPublished CVE record published
2026-06-17 05:14 UTCUpdated Record last modified

gbgplc acuant acufill sdk UPGRADE

Affected: < 10.22.02.03

Fixed in: 10.22.02.03

Safe to downgrade to: no unaffected older release

1. Check installed version

apt-cache policy acuant-acufill-sdk || rpm -q acuant-acufill-sdk || acuant-acufill-sdk --version

2. UPGRADE to 10.22.02.03 (Debian / Ubuntu)

sudo apt update && sudo apt install --only-upgrade acuant-acufill-sdk

2. UPGRADE (RHEL / Amazon Linux / Fedora)

sudo dnf upgrade acuant-acufill-sdk

Note

Distros often backport fixes without changing the version number. Confirm with the distro advisory or changelog.

Verify at the official source NVD · CVE Program · Report a problem with this page
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.

Quick answers

How do I fix CVE-2022-48226?

acuant acufill sdk: upgrade to 10.22.02.03. Exact commands for each OS are on this page.

Is CVE-2022-48226 being exploited?

CVE-2022-48226 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

What does CVE-2022-48226 affect?

CVE-2022-48226 affects acuant acufill sdk. Severity is high (CVSS 7.8). An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need

How urgent is CVE-2022-48226?

Priority 29/100. High severity

Software pages

Windows vulnerabilities

Related CVEs

CVE-2022-48225 HIGH 7.3 UPGRADE An issue was discovered in Acuant AcuFill SDK before 10.22.02.03
CVE-2022-48224 HIGH 7.3 UPGRADE An issue was discovered in Acuant AcuFill SDK before 10.22.02.03
CVE-2022-48223 MEDIUM 6.7 UPGRADE An issue was discovered in Acuant AcuFill SDK before 10.22.02.03
CVE-2022-48222 HIGH 7.8 UPGRADE An issue was discovered in Acuant AcuFill SDK before 10.22.02.03
CVE-2022-48221 HIGH 7.5 UPGRADE An issue was discovered in Acuant AcuFill SDK before 10.22.02.03

References

← Back to latest CVEs